• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.45% Nasdaq Down 1.03%

    Idera Pharmaceuticals, Inc. (IDRA)

    -NasdaqCM
    4.52 Down 0.18(3.83%) Jan 30, 4:00PM EST
    |After Hours : 4.52 0.00 (0.00%) Jan 30, 4:49PM EST
    Add to Portfolio
    Prev Close:4.70
    Open:4.66
    Bid:N/A
    Ask:5.05 x 2000
    1y Target Est:7.00
    Beta:2.89
    Earnings Date:Mar 11 - Mar 16 (Est.)
    Day's Range:4.51 - 4.79
    52wk Range:1.94 - 6.87
    Volume:1,087,338
    Avg Vol (3m):1,932,430
    Market Cap:387.86M
    P/E (ttm):N/A
    EPS (ttm):-0.44
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for IDRA

    Comparison

    Symbol% ChgMkt Cap
    IDRADown 3.83%387.86M
    DVAX 0.00%449.61M
    PFEDown 1.82%196.90B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):5,377.43
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.45
    Quarterly EPS Est (Dec-14) :-0.12
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Idera Pharmaceuticals, Inc., a clinical stage biotechnology company, is engaged in the discovery and development of novel therapeutics that modulate immune responses through toll-like receptors (TLRs) in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback